1317 related articles for article (PubMed ID: 35924232)
21. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
Wang L; Wang L; He P
Front Genet; 2022; 13():1064432. PubMed ID: 36568383
[No Abstract] [Full Text] [Related]
22. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
23. A prognostic nomogram integrating novel biomarkers identified by machine learning for cervical squamous cell carcinoma.
Li Y; Lu S; Lan M; Peng X; Zhang Z; Lang J
J Transl Med; 2020 Jun; 18(1):223. PubMed ID: 32503630
[TBL] [Abstract][Full Text] [Related]
24. Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
Li H; Zhang X; Yi C; He Y; Chen X; Zhao W; Yu D
BMC Cancer; 2021 Jul; 21(1):835. PubMed ID: 34284753
[TBL] [Abstract][Full Text] [Related]
25. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma.
Yang F; Zhou LQ; Yang HW; Wang YJ
Front Genet; 2022; 13():927614. PubMed ID: 36092911
[No Abstract] [Full Text] [Related]
26. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma.
Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B
Front Oncol; 2022; 12():915662. PubMed ID: 36033441
[TBL] [Abstract][Full Text] [Related]
27. Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma.
Zhang Z; Lin E; Zhuang H; Xie L; Feng X; Liu J; Yu Y
Cancer Cell Int; 2020; 20():27. PubMed ID: 32002016
[TBL] [Abstract][Full Text] [Related]
28. Risk stratification and prognosis prediction based on inflammation-related gene signature in lung squamous carcinoma.
Zhai W; Chen S; Duan F; Wang J; Zhao Z; Lin Y; Rao B; Wang Y; Zheng L; Long H
Cancer Med; 2023 Feb; 12(4):4968-4980. PubMed ID: 36056909
[TBL] [Abstract][Full Text] [Related]
29. Identification of immune related molecular subtypes and prognosis model for predicting prognosis, drug resistance in cervical squamous cell carcinoma.
Hu D; Zhang Z; Zhang Y; Huang K; Li X
Front Genet; 2023; 14():1137995. PubMed ID: 37007965
[No Abstract] [Full Text] [Related]
30. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
Zhang Z; Wang J; Han W; Zhao L
BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
[TBL] [Abstract][Full Text] [Related]
31. Identification of
Zhao S; Yu M
DNA Cell Biol; 2020 Feb; 39(2):255-272. PubMed ID: 31977248
[TBL] [Abstract][Full Text] [Related]
32. A novel DNA damage repair-related gene signature predicting survival, immune infiltration and drug sensitivity in cervical cancer based on single cell sequencing.
Xiang X; Kang J; Jiang J; Zhang Y; Zhang Y; Li L; Peng X
Front Immunol; 2023; 14():1198391. PubMed ID: 37449209
[TBL] [Abstract][Full Text] [Related]
33. Identification of ferroptosis-related molecular subtypes and a methylation-related ferroptosis gene prognostic signature in cervical squamous cell carcinoma.
Yu L; Gao Z; Li Z; Liu P; Gao Y; Liang G
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14673-14689. PubMed ID: 37584713
[TBL] [Abstract][Full Text] [Related]
34. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
35. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer.
Zhang C; Zeng C; Xiong S; Zhao Z; Wu G
Sci Rep; 2022 Nov; 12(1):18688. PubMed ID: 36333388
[TBL] [Abstract][Full Text] [Related]
36. Identification of EPHX2 and RMI2 as two novel key genes in cervical squamous cell carcinoma by an integrated bioinformatic analysis.
Liu J; Nie S; Gao M; Jiang Y; Wan Y; Ma X; Zhou S; Cheng W
J Cell Physiol; 2019 Nov; 234(11):21260-21273. PubMed ID: 31041817
[TBL] [Abstract][Full Text] [Related]
37. A 15-Gene Signature and Prognostic Nomogram for Predicting Overall Survival in Non-Distant Metastatic Oral Tongue Squamous Cell Carcinoma.
Liu M; Tong L; Liang B; Song X; Xie L; Peng H; Huang D
Front Oncol; 2021; 11():587548. PubMed ID: 33767977
[TBL] [Abstract][Full Text] [Related]
38. Identification and Verification of Immune-Related Genes Prognostic Signature Based on ssGSEA for Adrenocortical Carcinoma (ACC).
Yuan K; Zeng R; Deng P; Zhang A; Liu H; Wang N; Tang Y; Yin Z; Liu H
Int J Gen Med; 2022; 15():1471-1483. PubMed ID: 35210821
[TBL] [Abstract][Full Text] [Related]
39. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
40. A cellular senescence-related genes model allows for prognosis and treatment stratification of cervical cancer: a bioinformatics analysis and external verification.
Yang W; An L; Li Y; Qian S
Aging (Albany NY); 2023 Sep; 15(18):9408-9425. PubMed ID: 37768206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
